mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |